ada.enesco, Author at European Medical Journal - Page 23 of 65

Paediatric HIV Study Backs New Second-Line Antiretroviral Therapy

A new study provides strong evidence supporting the use of dolutegravir and TAF-emtricitabine for second-line antiretroviral therapy in children.

Increasing UV Exposure and Rising Melanoma Risk in Canada

Young adults (18–29 years) had the highest UV exposure and sunburn rates, and were least likely to use protective clothing.

New COPD Criteria Spot High-Risk Patients Missed by Spirometry

Including imaging and symptom-based data in COPD diagnosis captures patients with high-risk disease who would otherwise be overlooked by spirometry alone.

Resolved Hepatitis B Infection Linked to Increased Depression Risk

The study raises important concerns about the long-term mental health of individuals with resolved HBV infection.

ASCoP Registry: New Data Support Staging TAVI and PCI in Severe Aortic Stenosis

Staged TAVI and complex PCI reduce complications compared to combined procedures in patients with severe aortic stenosis.

New Multiplex Test Boosts Detection of Tick-Borne Infections

A new multiplex protein microarray has shown promise in accurately detecting a wide range of tick-borne infections in a single test run.

Single-Dose Primaquine Cuts Malaria Spread Without Added Risk

A single low dose of primaquine, when added to artemisinin-based combination therapy, is both effective and safe for reducing Plasmodium falciparum transmission.

Emotional and Physical Toll of Childhood Atopic Dermatitis

Safety concerns surrounding certain therapies in children often lead to suboptimal management of atopic dermatitis.

Climatic Factors Drive Oropouche Virus Spread Across Latin America

A large-scale study has identified key predictors of Oropouche virus transmission risk across Latin America, providing insights into the 2023–24 outbreak.

Nasal Epithelial Assays Predict Cystic Fibrosis Clinical Outcomes

A new study supports the clinical utility of human nasal epithelial cultures as predictive biomarkers for cystic fibrosis CFTR modulator therapy.